Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07392008 · ClinicalTrials.gov registry record · NA

PASO A PASO: Tailored Diabetes Prevention Program for Spanish-Speaking Communities Feasibility Study

A NA study of Pre-diabetic, sponsored by University of Utah.

Active
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT07392008 is a NA study of Pre-diabetic that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07392008, a NA study of Pre-diabetic, is active but no longer recruiting, sponsored by University of Utah.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The interdisciplinary and interprofessional community-academic partnership (CAP) has been working with Spanish-speaking H/L Salt Lake City residents and organization leaders to adapt the National Diabetes Prevention Program to meet the needs of this population. This next collaboration phase attempts to finalize the adapted diabetes prevention program, "Paso a Paso," and evaluate its feasibility and implementation strategies. The purpose of this pilot study is to inform the necessary modifications to the Paso a Paso diabetes prevention intervention, ensuring that the full-scale future intervention is both feasible and effective for the target community.

Conditions Studied

Interventions

  • BEHAVIORAL Paso a Paso

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2025-07-01
Est. Completion 2026-03-31
Phase NA

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT07392008

The ClinicalTrials.gov registry entry for NCT07392008 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pre-diabetic appearing as the primary indexed condition, and to 1 intervention - of which Paso a Paso is the first listed.

NCT07392008 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT07392008 about?

NCT07392008 is a clinical study titled "PASO A PASO: Tailored Diabetes Prevention Program for Spanish-Speaking Communities Feasibility Study". The interdisciplinary and interprofessional community-academic partnership (CAP) has been working with Spanish-speaking H/L Salt Lake City residents and organization leaders to adapt the National Diabetes Prevention Program to meet the needs of this population. This next collaboration phase attempts...

What is the current status of trial NCT07392008?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-07-01. Estimated completion is 2026-03-31.

What conditions does trial NCT07392008 study?

This clinical trial studies the following conditions: Pre-diabetic.

What interventions are being tested in trial NCT07392008?

The interventions under investigation include: Paso a Paso (BEHAVIORAL).

Who is sponsoring clinical trial NCT07392008?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07392008 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pre-diabetic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.